This overlap is largely why VUG has outperformed the S&P 500 over the years. These have been some of the best-performing stocks on th ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 6.54% at $68.29. The stock trailed the S&P 500, which registered a daily gain of 1.56%. On the other hand, the Dow registered a ...

CRISPR Therapeutics (CRSP) has filed a prospectus supplement with the U.S. SEC to sell up to $600 million worth of its common ...

CRISPR Therapeutics’ stock is surging as in-vivo therapies show promise. Learn about CRSP stock's risks, long-term upside, ...

Fintel reports that on October 17, 2025, B of A Securities maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

The ETF jumped 46% in 2023, and then another 32% in 2024, and is up 16% year to date. The 46% gain in 2023 shows a 39% jump ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The tariff-driven market volatility has been rough on ...

Novo Nordisk saw a competitor’s bet and raised the stakes in metabolic dysfunction-associated steatohepatitis (MASH) with its planned up-to-$5.2 billion acquisition of Akero Therapeutics.

The ROG Xbox Ally and Xbox Ally X are available now (October 16). If you didn't preorder one of the devices, you can still get the first Xbox handheld during launch week. Best Buy has updated its ...

The Senate for a tenth time Thursday rejected a GOP-backed measure to reopen the government, blocking the funding bill from moving forward with no new supporters, indicating negotiations remain at a ...